ConductScience.org, home

Paper20174468

Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.

Crews L and 9 others. PLoS One, 2010. Cited by 301 papers, by iCite. Retracted.

Cite this record

ConductScience Library. Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. Papers, record 20174468. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20174468

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy.
PubMed
Journal
PLoS One
PubMed
Year
2010
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Retracted Publication
PubMed
Citations, by iCite
301
iCite
Relative citation ratio, by iCite
7.56
iCite
Retracted
Yes, by PubMed's record
PubMed
Revised in PubMed
2024-11-13
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Crews LLeslie
2Spencer BBrian
3Desplats PPaula
4Patrick CChristina
5Paulino AAmy
6Rockenstein EEdward
7Hansen LLawrence
8Adame AAnthony
9Galasko DDouglas
10Masliah EEliezer

Source PubMed

Download CSV of authors

Topics25

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
AutophagyMajor topic
Lewy Body DiseaseMajor topic
alpha-SynucleinMajor topic
Aged
Aged, 80 and over
Animals
Autophagy-Related Protein 7
Blotting, Western
Brain
Cell Line
Cell Line, Tumor
Disease Models, Animal
Female
Humans
Male
Mice
Mice, Transgenic
Microscopy, Confocal
Microscopy, Electron
Nerve Degeneration
Pyramidal Cells
RNA Interference
Signal Transduction
Ubiquitin-Activating Enzymes

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P50 AG005131NIA NIH HHSUnited StatesP50AG005131PubMed and NIHNIH RePORTER
R01 AG018440NIA NIH HHSUnited StatesR01AG018440PubMed and NIHNIH RePORTER
R37 AG018440NIA NIH HHSUnited StatesR01AG018440PubMed and NIHNIH RePORTER
AG18440NIA NIH HHSUnited StatesR01AG018440PubMed and NIHNIH RePORTER
AG5131NIA NIH HHSUnited StatesP50AG005131PubMed and NIHNIH RePORTER
R37AG018440NIHNIH RePORTER

Download CSV of grants

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Retracted by39536070Retraction: Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy.https://conductscience.org/library/papers/39536070

Source PubMed

Download CSV of comments and corrections

References89

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116772866Autophagic stress in neuronal injury and disease.J Neuropathol Exp Neurol2006https://conductscience.org/library/papers/16772866PubMed
211470957Alpha-synuclein and the Lewy body disorders.Curr Opin Neurol2001https://conductscience.org/library/papers/11470957PubMed
319864570Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases.J Neurosci2009https://conductscience.org/library/papers/19864570PubMed
416825955Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.J Neuropathol Exp Neurol2006https://conductscience.org/library/papers/16825955PubMed
512367530Alpha-synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils.J Mol Biol2002https://conductscience.org/library/papers/12367530PubMed
615333840Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy.Science2004https://conductscience.org/library/papers/15333840PubMed
716211595Cognitive profiles of individual patients with Parkinson's disease and dementia: comparison with dementia with lewy bodies and Alzheimer's disease.Mov Disord2006https://conductscience.org/library/papers/16211595PubMed
811572944beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11572944PubMed
910991663Pathoanatomy of Parkinson's disease.J Neurol2000https://conductscience.org/library/papers/10991663PubMed
1018287526Organization of the pre-autophagosomal structure responsible for autophagosome formation.Mol Biol Cell2008https://conductscience.org/library/papers/18287526PubMed
1115804428Alpha-synuclein-positive structures induced in leupeptin-infused rats.Brain Res2005https://conductscience.org/library/papers/15804428PubMed
1210818140High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.J Neurosci2000https://conductscience.org/library/papers/10818140PubMed
139598683Frontal cortical synaptophysin in Lewy body diseases: relation to Alzheimer's disease and dementia.J Neurol Neurosurg Psychiatry1998https://conductscience.org/library/papers/9598683PubMed
1411327633Subcellular localization of angiotensin II in kidney and adrenal.J Hypertens2001https://conductscience.org/library/papers/11327633PubMed
1511181819Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult.J Neurochem2001https://conductscience.org/library/papers/11181819PubMed
1612376616Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.Proc Natl Acad Sci U S A2002https://conductscience.org/library/papers/12376616PubMed
1712168801Autophagy in neurons: a review.Histol Histopathol2002https://conductscience.org/library/papers/12168801PubMed
1812657655Neprilysin gene transfer reduces human amyloid pathology in transgenic mice.J Neurosci2003https://conductscience.org/library/papers/12657655PubMed
1912390510The neuropathogenic contributions of lysosomal dysfunction.J Neurochem2002https://conductscience.org/library/papers/12390510PubMed
2012769185Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis--an approach for slowing Alzheimer disease?J Neuropathol Exp Neurol2003https://conductscience.org/library/papers/12769185PubMed

See all 89 referencesDownload CSV of references

Cited by212

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 301 citations.

PMIDTitleJournalYearIn PapersSource
41351663Navigating the Autophagy Maze: ATG and Their Impact on Neurodegenerative Diseases.Mol Neurobiol2025https://conductscience.org/library/papers/41351663PubMed
412475293-Acetyl-11-Keto-β-Boswellic acid (AKBA) Attenuated 6-Hydroxydopamine (6-OHDA)-Induced Toxicity in SH-SY5Y Cells via Modulation of Akt/mTOR Pathway.Mol Neurobiol2025https://conductscience.org/library/papers/41247529PubMed
41189817Analytical Review on Normal Brain Aging, Alzheimer's Disease, and Stage 4S Neuroblastoma: Novel Insights Into Neuroprotection, Neurodegeneration, and Spontaneous Regression.Cureus2025https://conductscience.org/library/papers/41189817PubMed
40584900The promise of gene therapy in common types of dementia.Bioimpacts2025https://conductscience.org/library/papers/40584900PubMed
40357169Targeting autophagy in astrocytes: a potential for neurodegenerative disease intervention.Front Cell Neurosci2025https://conductscience.org/library/papers/40357169PubMed
39949604Canonical and noncanonical autophagy: involvement in Parkinson's disease.Front Cell Dev Biol2025https://conductscience.org/library/papers/39949604PubMed
39904669Fibrinogen degradation products exacerbate alpha-synuclein aggregation by inhibiting autophagy via downregulation of Beclin1 in multiple system atrophy.Neurotherapeutics2025https://conductscience.org/library/papers/39904669PubMed
39759118TFE3-mediated neuroprotection: Clearance of aggregated α-synuclein and accumulated mitochondria in the AAV-α-synuclein model of Parkinson's disease.Genes Dis2025https://conductscience.org/library/papers/39759118PubMed
39536070Retraction: Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy.PLoS One2024https://conductscience.org/library/papers/39536070PubMed
39431275The potential of exosomal biomarkers: Revolutionizing Parkinson's disease: How do they influence pathogenesis, diagnosis, and therapeutic strategies?AIMS Neurosci2024https://conductscience.org/library/papers/39431275PubMed
39223418Lysosomal dysfunction in α-synuclein pathology: molecular mechanisms and therapeutic strategies.Cell Mol Life Sci2024https://conductscience.org/library/papers/39223418PubMed
39026991Emerging perspectives on precision therapy for Parkinson's disease: multidimensional evidence leading to a new breakthrough in personalized medicine.Front Aging Neurosci2024https://conductscience.org/library/papers/39026991PubMed
38899618Novel autophagy inducers by accelerating lysosomal clustering against Parkinson's disease.Elife2024https://conductscience.org/library/papers/38899618PubMed
38600347Key genes and convergent pathogenic mechanisms in Parkinson disease.Nat Rev Neurosci2024https://conductscience.org/library/papers/38600347PubMed
38476326Melatonin derivative 6a as a PARP-1 inhibitor for the treatment of Parkinson's disease.Front Pharmacol2024https://conductscience.org/library/papers/38476326PubMed
38430248Autophagy and UPS pathway contribute to nicotine-induced protection effect in Parkinson's disease.Exp Brain Res2024https://conductscience.org/library/papers/38430248PubMed
38390593Latest advances in mechanisms of epileptic activity in Alzheimer's disease and dementia with Lewy Bodies.Front Neurol2024https://conductscience.org/library/papers/38390593PubMed
38256197Autophagy Markers Are Altered in Alzheimer's Disease, Dementia with Lewy Bodies and Frontotemporal Dementia.Int J Mol Sci2024https://conductscience.org/library/papers/38256197PubMed
38203531Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson's Disease.Int J Mol Sci2023https://conductscience.org/library/papers/38203531PubMed
37928387The role of exosomes in the diagnosis of Parkinson's disease.Heliyon2023https://conductscience.org/library/papers/37928387PubMed

See all 212 cited byDownload CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20174468

GET https://conductscience.org/api/papers/v1/20174468/references?page=2